Atlas Trials

A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)

Clinical trial NCT07237282 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07237282
Sponsor
University of Alberta
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2026-08-01
Primary completion
2027-01-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.